The PIH trainings will bring together public health officials and leaders responsible for overseeing MDR-TB programs in Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Ukraine and Uzbekistan.
A second session in June, also funded by the Lilly grant to PIH/BWH, will bring TB physicians from these same 10 countries to the TB Research Institute at Novosibirsk in Siberia, one of five Russian TB Centers where PIH and BWH faculty have provided education programs to physicians over the last two years. The Institute, recently designated by the World Health Organization as a Center of Excellence, will provide a two-week clinical education program in MDR-TB.
June also marks a milestone in an international partnership between Lilly, PIH, BWH, the Moscow Medical Academy and the Harvard School of Public Health, which for several years has brought Russian physicians to Boston for a 7-week program in quantitative research methods and evidence-based medicine, with some of the physicians ultimately earning a Masters in Public Health. This newly trained cadre of experienced Russian faculty now will be joined by Harvard faculty to begin teaching advanced methods of biostatistics and epidemiology in Moscow to medical students and practicing physicians. The program promises not only to improve TB research and treatment, but also to more generally improve medical care in Russia and the Former Soviet Republics.
In addition to the doctors being trained this year, PIH-led sessions have provided education to 375 physicians, representing all 88 territories of the Russian Federation.
In conjunction with the Research Center in Novosibirsk, Tom
|SOURCE Eli Lilly and Company|
Copyright©2008 PR Newswire.
All rights reserved